Loading…

Lenalidomide in multiple myeloma

Saved in:
Bibliographic Details
Published in:The lancet oncology 2007-10, Vol.8 (10), p.872-872
Main Author: Bagchi, Sanjit
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 872
container_issue 10
container_start_page 872
container_title The lancet oncology
container_volume 8
creator Bagchi, Sanjit
description
doi_str_mv 10.1016/S1470-2045(07)70304-2
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68454223</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1470204507703042</els_id><sourcerecordid>1665206471</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-b40298d9c666f0cfc1de42eb9a49d553d6fe676472280ca7338118806c2189993</originalsourceid><addsrcrecordid>eNqFkMtKxDAUQIMoOo5-gjK4EF1Ubx7NY6OI-IIBF-o6dJJbiKbt2EyF-Xs700HBjauEcO4J9xByROGCApWXL1QoyBiI_AzUuQIOImNbZNQ_iywXWm-v7wOyR_ZTegegikK-S_aoMkpAzkZkMsW6iME3VfA4CfWk6uIizCNOqiXGpioOyE5ZxISHm3NM3u7vXm8fs-nzw9PtzTRz3PBFNhPAjPbGSSlLcKWjHgXDmSmE8XnOvSxRKikUYxpcoTjXlGoN0jGqjTF8TE4H77xtPjtMC1uF5DDGosamS1ZqkQvGeA-e_AHfm67tl0iWARjoxSsoHyDXNim1WNp5G6qiXVoKdtXPrvvZVRwLyq77WdbPHW_k3axC_zu1CdYD1wOAfYuvgK1NLmDt0IcW3cL6Jvz7xdUfg4uhDq6IH7jE9LMMtYlZGCQrB6i1gfFvFU-Qsw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>200903813</pqid></control><display><type>article</type><title>Lenalidomide in multiple myeloma</title><source>Elsevier:Jisc Collections:Elsevier Read and Publish Agreement 2022-2024:Freedom Collection (Reading list)</source><creator>Bagchi, Sanjit</creator><creatorcontrib>Bagchi, Sanjit</creatorcontrib><identifier>ISSN: 1470-2045</identifier><identifier>EISSN: 1474-5488</identifier><identifier>DOI: 10.1016/S1470-2045(07)70304-2</identifier><identifier>PMID: 17974052</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Aged ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Hematology, Oncology and Palliative Medicine ; Humans ; Multiple Myeloma - drug therapy ; Multiple Myeloma - mortality ; Thalidomide - administration &amp; dosage ; Thalidomide - analogs &amp; derivatives</subject><ispartof>The lancet oncology, 2007-10, Vol.8 (10), p.872-872</ispartof><rights>2007</rights><rights>Copyright Elsevier Limited Oct 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17974052$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bagchi, Sanjit</creatorcontrib><title>Lenalidomide in multiple myeloma</title><title>The lancet oncology</title><addtitle>Lancet Oncol</addtitle><subject>Aged</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Multiple Myeloma - drug therapy</subject><subject>Multiple Myeloma - mortality</subject><subject>Thalidomide - administration &amp; dosage</subject><subject>Thalidomide - analogs &amp; derivatives</subject><issn>1470-2045</issn><issn>1474-5488</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkMtKxDAUQIMoOo5-gjK4EF1Ubx7NY6OI-IIBF-o6dJJbiKbt2EyF-Xs700HBjauEcO4J9xByROGCApWXL1QoyBiI_AzUuQIOImNbZNQ_iywXWm-v7wOyR_ZTegegikK-S_aoMkpAzkZkMsW6iME3VfA4CfWk6uIizCNOqiXGpioOyE5ZxISHm3NM3u7vXm8fs-nzw9PtzTRz3PBFNhPAjPbGSSlLcKWjHgXDmSmE8XnOvSxRKikUYxpcoTjXlGoN0jGqjTF8TE4H77xtPjtMC1uF5DDGosamS1ZqkQvGeA-e_AHfm67tl0iWARjoxSsoHyDXNim1WNp5G6qiXVoKdtXPrvvZVRwLyq77WdbPHW_k3axC_zu1CdYD1wOAfYuvgK1NLmDt0IcW3cL6Jvz7xdUfg4uhDq6IH7jE9LMMtYlZGCQrB6i1gfFvFU-Qsw</recordid><startdate>20071001</startdate><enddate>20071001</enddate><creator>Bagchi, Sanjit</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20071001</creationdate><title>Lenalidomide in multiple myeloma</title><author>Bagchi, Sanjit</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-b40298d9c666f0cfc1de42eb9a49d553d6fe676472280ca7338118806c2189993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Aged</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Multiple Myeloma - drug therapy</topic><topic>Multiple Myeloma - mortality</topic><topic>Thalidomide - administration &amp; dosage</topic><topic>Thalidomide - analogs &amp; derivatives</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bagchi, Sanjit</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>The lancet oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bagchi, Sanjit</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lenalidomide in multiple myeloma</atitle><jtitle>The lancet oncology</jtitle><addtitle>Lancet Oncol</addtitle><date>2007-10-01</date><risdate>2007</risdate><volume>8</volume><issue>10</issue><spage>872</spage><epage>872</epage><pages>872-872</pages><issn>1470-2045</issn><eissn>1474-5488</eissn><coden>LANCAO</coden><cop>England</cop><pub>Elsevier Ltd</pub><pmid>17974052</pmid><doi>10.1016/S1470-2045(07)70304-2</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1470-2045
ispartof The lancet oncology, 2007-10, Vol.8 (10), p.872-872
issn 1470-2045
1474-5488
language eng
recordid cdi_proquest_miscellaneous_68454223
source Elsevier:Jisc Collections:Elsevier Read and Publish Agreement 2022-2024:Freedom Collection (Reading list)
subjects Aged
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Hematology, Oncology and Palliative Medicine
Humans
Multiple Myeloma - drug therapy
Multiple Myeloma - mortality
Thalidomide - administration & dosage
Thalidomide - analogs & derivatives
title Lenalidomide in multiple myeloma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T03%3A26%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lenalidomide%20in%20multiple%20myeloma&rft.jtitle=The%20lancet%20oncology&rft.au=Bagchi,%20Sanjit&rft.date=2007-10-01&rft.volume=8&rft.issue=10&rft.spage=872&rft.epage=872&rft.pages=872-872&rft.issn=1470-2045&rft.eissn=1474-5488&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1470-2045(07)70304-2&rft_dat=%3Cproquest_cross%3E1665206471%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c393t-b40298d9c666f0cfc1de42eb9a49d553d6fe676472280ca7338118806c2189993%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=200903813&rft_id=info:pmid/17974052&rfr_iscdi=true